Related Experiment Video
Updated: Jun 15, 2026

09:52
Histological Quantification to Determine Lung Fungal Burden in Experimental Aspergillosis
Published on: March 9, 2018
[Fungal sinusitis diagnostic management and classification]
Acta Chirurgica Iugoslavica
|March 12, 2010
Summary
This study reviews fungal sinusitis classification, diagnosis, and treatment in 31 patients. It highlights key diagnostic features for mycetoma, chronic non-invasive, and allergic fungal sinusitis in immunocompetent individuals.
Area of Science:
- Otolaryngology
- Mycology
- Immunology
Context:
- Fungal sinusitis presents a diagnostic challenge, particularly in immunocompetent patients.
- Accurate classification is crucial for effective management and treatment strategies.
- This study focuses on differentiating key subtypes of fungal sinusitis based on clinical presentation and diagnostic findings.
Purpose:
- To present the current classification of fungal sinusitis.
- To share experiences in diagnostic procedures for fungal sinusitis subtypes.
- To report treatment outcomes for fungal sinusitis patients.
Summary:
- The study analyzed 31 immunocompetent patients diagnosed with fungal sinusitis between 2000-2009.
- Diagnoses included mycetoma (10), chronic non-invasive fungal sinusitis (16), and allergic fungal sinusitis (5).
- Diagnostic criteria involved CT imaging, pathohistology (Grocott stain), eosinophilia, skin tests, and IgE levels, with all patients treated with topical steroids and saline irrigation.
Impact:
- Provides clear diagnostic criteria for differentiating fungal sinusitis subtypes.
- Demonstrates effective non-fungicidal treatment approaches for fungal sinusitis.
- Contributes to improved understanding and management of fungal sinusitis in clinical practice.
Related Concept Videos
Cryptococcal Meningitis
Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Cystic Fibrosis: Management
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Sinus disease and chronic sinusitis...
Fungal Phylum Microsporidia
Microsporidia are a group of obligate intracellular fungi that were initially classified as protists but were later reclassified based on phylogenetic, molecular, and structural evidence linking them to the Chytridiomycota. These unicellular, non-motile organisms are highly specialized parasites that infect a wide range of animal hosts, including humans. They have evolved extensive genomic and metabolic reductions, making them highly dependent on their hosts for survival.Morphology and Genomic...
Endocarditis III: Medical Management
Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
Brain Abscess l: Introduction
A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Pneumonia IV: Management
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include: